Detalles de la búsqueda
1.
Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
N Engl J Med
; 381(25): 2429-2439, 2019 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31661198
2.
Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis.
N Engl J Med
; 379(17): 1621-1634, 2018 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280651
3.
Assessment of Mumps Virus-Specific Antibodies: Comparison of Plaque Reduction Neutralization Test and Enzyme-Linked Immunosorbent Assay Estimates.
J Infect Dis
; 220(9): 1462-1468, 2019 09 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31299077
4.
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: a phase III, double-blind, randomized study.
BMC Pediatr
; 19(1): 50, 2019 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30732648
5.
Long-term booster schedules with AS03A-adjuvanted heterologous H5N1 vaccines induces rapid and broad immune responses in Asian adults.
BMC Infect Dis
; 14: 142, 2014 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24628789
6.
Effect of human rotavirus vaccine on severe diarrhea in African infants.
N Engl J Med
; 362(4): 289-98, 2010 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20107214
7.
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.
BMC Infect Dis
; 13: 435, 2013 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041010
8.
Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.
BMC Infect Dis
; 12: 162, 2012 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22824474
9.
Safety and immunogenicity of a split-virion AS03A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults.
J Formos Med Assoc
; 111(6): 333-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748624
10.
Immunogenicity profile of a 3.75-µg hemagglutinin pandemic rH5N1 split virion AS03A-adjuvanted vaccine in elderly persons: a randomized trial.
J Infect Dis
; 203(8): 1054-62, 2011 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21450995
11.
Subsequent AS01-adjuvanted vaccinations induce similar transcriptional responses in populations with different disease statuses.
PLoS One
; 17(11): e0276505, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36355775
12.
[Cancer imaging and prevention of renal failure]. / Imagerie des cancers et prévention de l'insuffisance rénale.
Bull Cancer
; 2022 Nov 09.
Artículo
en Francés
| MEDLINE | ID: mdl-36371283
13.
Cross-clade immunogenicity and antigen-sparing with an AS03(A)-adjuvanted prepandemic influenza vaccine in a Thai population.
J Med Assoc Thai
; 94(8): 916-26, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21863672
14.
Clinically- versus serologically-identified varicella: A hidden infection burden. A ten-year follow-up from a randomized study in varicella-endemic countries.
Hum Vaccin Immunother
; 17(10): 3747-3756, 2021 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34181506
15.
Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants.
Vaccine
; 39(25): 3445-3454, 2021 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33736915
16.
Immunogenicity and safety of a novel AS03(A)-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan.
Hum Vaccin
; 6(11): 888-93, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20980795
17.
Comparison of a glycoprotein E-based ELISA with a varicella-zoster whole-virus ELISA for the quantification of varicella vaccine immune responses in young children.
Vaccine
; 38(17): 3300-3304, 2020 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32184033
18.
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
J Pediatric Infect Dis Soc
; 9(2): 194-201, 2020 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30849175
19.
Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.
Lancet
; 371(9619): 1181-9, 2008 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-18395579
20.
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
N Engl J Med
; 354(1): 11-22, 2006 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-16394298